LIMNW vs MRVL
Liminatus Pharma, Inc. Warrants (LIMNW) versus Marvell Technology Group Ltd (MRVL) — a side-by-side from cached financials, not a winner call.
Liminatus Pharma, Inc. Warrants (LIMNW) is a biotechnology company listed on US.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ. It is led by Matthew J. Murphy.
LIMNW does not have a complete income-statement cache yet.
Latest reported MRVL revenue for 2026-08-01 was $5.16B. Net income was $342.5M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
LIMNW currently screens at market cap $0. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
Not investment advice. Open the LIMNW and MRVL stock pages for the full models.
Not investment advice.